Handelsinvest Investeringsforvaltning’s PTC Therapeutics PTCT Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-103,700	Closed	-$5.21M	–	109
2022 Q3	$5.21M	Buy	103,700 +2,800	+3%	+$137K	0.82%	45
2022 Q2	$4.04M	Buy	100,900 +25,900	+35%	+$908K	0.6%	59
2022 Q1	$2.8M	Hold	75,000	–	–	0.34%	92
2021 Q4	$2.99M	Hold	75,000	–	–	0.3%	100
2021 Q3	$2.79M	Hold	75,000	–	–	0.3%	105
2021 Q2	$3.17M	Hold	75,000	–	–	0.35%	99
2021 Q1	$3.55M	Sell	75,000 -5,000	-6%	-$297K	0.43%	88
2020 Q4	$4.88M	Buy	80,000 +20,000	+33%	+$1.18M	0.73%	57
2020 Q3	$2.81M	Buy	60,000 +10,000	+20%	+$492K	0.53%	59
2020 Q2	$2.54M	Hold	50,000	–	–	0.53%	57
2020 Q1	$2.23M	Hold	50,000	–	–	0.59%	55
2019 Q4	$2.4M	Buy	50,000 +30,000	+150%	+$1.27M	0.48%	63
2019 Q3	$676K	Hold	20,000	–	–	0.15%	99
2019 Q2	$900K	Buy	+20,000	New	+$790K	0.19%	86

Other funds holding PTCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's PTCT Position: Q4 2022 in Review

Handelsinvest Investeringsforvaltning sold out of PTC Therapeutics (PTCT) in Q4 2022, closing a stake of 103,700 shares — an estimated $5.21M sold.

Handelsinvest Investeringsforvaltning first reported a position in PTCT in Q2 2019 and held it in 14 quarters. The position peaked at $5.21M in Q3 2022. 203 funds tracked by Wall St. Rank hold PTCT as of Q4 2022.

Handelsinvest Investeringsforvaltning reported no remaining PTC Therapeutics position as of Q4 2022 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 103,700 PTC Therapeutics shares in Q4 2022, an estimated $5.21M.
Handelsinvest Investeringsforvaltning first reported a position in PTC Therapeutics in Q2 2019 and held it in 14 quarters.
Handelsinvest Investeringsforvaltning's PTC Therapeutics position peaked at $5.21M in Q3 2022.
203 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2022.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2022, filed 18 Jan 2023.